Search SEC
Fundamental Analysis
31 matches · 10756 cached companies
| Company | Fundamental | Momentum | Acceleration | Confidence | Revenue Growth | ROIC | FCF Growth | Op Margin Delta | Share Growth | Dividend Yield | Dividend Years | Payout Ratio | P/E | Signals |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ECLECOLAB INC. | 76.9 | 45 | 52.3 | 91 | +6.29% | +31.26% | n/a | +5.13% | -1.09% | 1.07% | 41 | 36.31% | 37.19x | Gross margin expansion, ROIC expansion, Net debt reduction, Share count reduction |
| IDXXIDEXX LABORATORIES INC /DE | 74.6 | 65.7 | 79.4 | 91 | +15.99% | +61.74% | n/a | +5.78% | -3.19% | 0% | 0 | n/a | n/a | Gross margin expansion, Operating leverage, ROIC expansion, Net debt reduction, Share count reduction, Strong operating leverage |
| ALABAstera Labs, Inc. | 81.3 | 100 | 100 | 79 | +170.9% | +60.23% | n/a | n/a | +2.93% | 0% | 0 | n/a | 170.94x | Operating leverage, Net debt reduction |
| PLABPHOTRONICS INC | 59.9 | 33.7 | 30 | 100 | +1.21% | +26.35% | -4.86% | -2.08% | -3.7% | 0% | 0 | n/a | 14.65x | Net debt reduction, Share count reduction3 warnings |
| ZLABZai Lab Ltd | 59.5 | 99.6 | 96.5 | 90 | +7.85% | -32.54% | n/a | +207.44% | +3.34% | 0% | 0 | n/a | n/a | Operating leverage, ROIC expansion, Net debt reduction2 warnings |
| GTLBGitlab Inc. | 62 | 100 | 100 | 85 | +35.21% | -13.05% | n/a | +62.31% | +2.56% | 0% | 0 | n/a | n/a | Operating leverage1 warning |
| PLPlanet Labs PBC | 61.8 | 100 | 60 | 83 | +46.49% | -261.82% | n/a | +71.64% | +19.76% | 0% | 0 | n/a | n/a | Gross margin expansion, Operating leverage, Net debt reduction2 warnings |
| DLBDolby Laboratories, Inc. | 49 | 23.5 | 24.6 | 100 | -1.23% | +10.31% | -23.52% | +4.71% | -3.03% | 2.45% | 13 | 60.24% | 24.97x | Net debt reduction, Share count reduction4 warnings |
| ESTAESTABLISHMENT LABS HOLDINGS INC. | 51.3 | 100 | 96.7 | 91 | +42.74% | -9.7% | n/a | +8.64% | +2.19% | 0% | 0 | n/a | n/a | Gross margin expansion, Operating leverage, ROIC expansion, Net debt reduction |
| MLABMESA LABORATORIES INC /CO/ | 51.2 | 64.6 | 66.1 | 91 | +5.69% | +7.61% | n/a | +9.16% | +6.04% | 0.48% | 24 | 52.49% | n/a | Gross margin expansion, Operating leverage, ROIC expansion, Net debt reduction, Strong operating leverage |
| USAQQHSLab, Inc. | 68.6 | 32 | 32 | 67 | +35.67% | +14.25% | n/a | +37.55% | +106.21% | 0% | 0 | n/a | n/a | Gross margin expansion, Net debt reduction5 warnings |
| PRLBProto Labs Inc | 63.2 | n/a | n/a | 71 | +17.59% | n/a | n/a | n/a | n/a | 0% | 0 | n/a | n/a | n/a |
| BLNDBlend Labs, Inc. | 48.9 | 100 | 100 | 84 | +7.26% | n/a | n/a | +249.95% | -7.45% | 0% | 0 | n/a | n/a | Gross margin expansion, Operating leverage, Share count reduction |
| LHLABCORP HOLDINGS INC. | 44.8 | 60.6 | 59.7 | 91 | +10.25% | +9.1% | n/a | -6.27% | -2.73% | 0.93% | 5 | 27.46% | n/a | Gross margin expansion, Operating leverage, ROIC expansion, Share count reduction, Strong operating leverage |
| STTKShattuck Labs, Inc. | 47.8 | 0 | 40 | 83 | -82.52% | -40.67% | n/a | -9,662.12% | +154.64% | 0% | 0 | n/a | n/a | ROIC expansion, Net debt reduction2 warnings |
| BIOBIO-RAD LABORATORIES, INC. | 37.1 | 51.7 | 52 | 91 | +2.55% | +2.92% | n/a | -7.34% | -4.08% | 0% | 0 | n/a | n/a | Operating leverage, ROIC expansion, Net debt reduction, Share count reduction, Strong operating leverage |
| BIO-BBIO-RAD LABORATORIES, INC. | 37.1 | 51.7 | 52 | 91 | +2.55% | +2.92% | n/a | -7.34% | -4.08% | 0% | 0 | n/a | n/a | Operating leverage, ROIC expansion, Net debt reduction, Share count reduction, Strong operating leverage |
| ABTABBOTT LABORATORIES | 37 | 50.4 | 43.8 | 91 | +9.78% | +8.76% | n/a | -3.33% | -0.03% | 2.54% | 44 | 63.09% | 29.24x | Gross margin expansion, Operating leverage, Share count reduction, Strong operating leverage1 warning |
| VIVSVivoSim Labs, INC. | 41.9 | 100 | 100 | 75 | -10.66% | n/a | n/a | +7,516.47% | +248.2% | 0% | 0 | n/a | n/a | Gross margin expansion, Operating leverage, Net debt reduction2 warnings |
| GROVGrove Collaborative Holdings, Inc. | 36.7 | 70.3 | 70.3 | 83 | -18.7% | n/a | n/a | +28.66% | +6.13% | 0% | 0 | n/a | n/a | Gross margin expansion, Operating leverage, Net debt reduction |
| GROVWGrove Collaborative Holdings, Inc. | 36.7 | 70.3 | 70.3 | 83 | -18.7% | n/a | n/a | +28.66% | +6.13% | 0% | 0 | n/a | n/a | Gross margin expansion, Operating leverage, Net debt reduction |
| CLBCore Laboratories Inc. /DE/ | 35.6 | 49.1 | 49.1 | 84 | -1.37% | +10.74% | n/a | n/a | +0.22% | 0.4% | 19 | 6.3% | 15.48x | Net debt reduction |
| CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 34.7 | 50.4 | 50.4 | 79 | +0.13% | +13.32% | n/a | -5.76% | -5.57% | 0% | 0 | n/a | 154.11x | Operating leverage, Share count reduction, Strong operating leverage |
| SLABSILICON LABORATORIES INC. | 28.8 | 100 | 100 | 84 | +41.06% | -7.42% | n/a | -22.6% | +2.28% | 0% | 0 | n/a | n/a | Gross margin expansion, Operating leverage |
| LABSTANDARD BIOTOOLS INC. | 23.5 | 100 | 100 | 90 | -25.17% | -37.13% | n/a | -18.67% | +3.35% | 0% | 0 | n/a | n/a | Operating leverage, ROIC expansion, Net debt reduction |
1-25 of 31